Clinical Trials Directory

Trials / Conditions / Refractory Adult Acute Lymphoblastic Leukemia

Refractory Adult Acute Lymphoblastic Leukemia

7 registered clinical trials studyying Refractory Adult Acute Lymphoblastic Leukemia — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingHA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After
NCT03326921
Fred Hutchinson Cancer CenterPhase 1
TerminatedhuJCAR014 CAR-T Cells in Treating Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Ac
NCT03103971
Fred Hutchinson Cancer CenterPhase 1
TerminatedNivolumab and Dasatinib in Treating Patients With Relapsed or Refractory Philadelphia Chromosome Positive Acut
NCT02819804
Northwestern UniversityPhase 1
CompletedSapanisertib in Treating Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia
NCT02484430
National Cancer Institute (NCI)Phase 2
WithdrawnVolasertib and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory Acute Lymphoblast
NCT02861040
Northwestern UniversityPhase 1
RecruitingPersonalized NK Cell Therapy in CBT
NCT02727803
M.D. Anderson Cancer CenterPhase 2
CompletedSelective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in
NCT01858740
Fred Hutchinson Cancer CenterPhase 2